(Q48385357)

11 February 2018

review article

1 reference

title

Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder responses (English)

1 reference

11 February 2018

obsessive-compulsive disorder

main subject

1 reference

Blier P

1

1 reference

11 February 2018

de Montigny C

series ordinal

2

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 September 1998

1 reference

11 February 2018

published in

Biological Psychiatry

1 reference

11 February 2018

volume

44

1 reference

11 February 2018

issue

5

1 reference

11 February 2018

page(s)

313-323

1 reference

11 February 2018

Pindolol Induces a Rapid Improvement of Depressed Patients Treated With Serotonin Reuptake Inhibitors

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

Effect of long-term administration of antidepressant treatments on serotonin release in brain regions involved in obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

Effectiveness of Pindolol With Selected Antidepressant Drugs in the Treatment of Major Depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

Modulation of 5-HT release in the guinea-pig brain following long-term administration of antidepressant drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

Serotoninergic but not noradrenergic neurons in rat central nervous system adapt to long-term treatment with monoamine oxidase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

Modification of 5-HT neuron properties by sustained administration of the 5-HT1A agonist gepirone: electrophysiological studies in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

Current advances and trends in the treatment of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

Short-term lithium treatment enhances responsiveness of postsynaptic 5-HT1A receptors without altering 5-HT autoreceptor sensitivity: an electrophysiological study in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

Long-term 5-HT reuptake blockade, but not monoamine oxidase inhibition, decreases the function of terminal 5-HT autoreceptors: an electrophysiological study in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

Serotonin function and mechanism of action of antidepressant treatment. Effects of amitriptyline and desipramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

Lithium addition in treatment-resistant depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

Tricyclic antidepressants: long-term treatment increases responsivity of rat forebrain neurons to serotonin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

In vivo electrophysiological characterization of 5-HT receptors in the guinea pig head of caudate nucleus and orbitofrontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

Alteration of serotonin release in the guinea pig orbito-frontal cortex by selective serotonin reuptake inhibitors. Relevance to treatment of obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

Serotonin, psilocybin, and body dysmorphic disorder: a case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

Citalopram — Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

Toward a neuroanatomy of obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

A controlled study of the antidepressant efficacy and side effects of (-)-deprenyl. A selective monoamine oxidase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

Serotonergic facilitation of facial motoneuron excitation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive-compulsive disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

Chronic antidepressant treatment enhances alpha-adrenergic and serotonergic responses in the facial nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

Serotonin autoreceptor subsensitivity and antidepressant activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

Differences between males and females in rates of serotonin synthesis in human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

A double-blind study of adjuvant buspirone hydrochloride in clomipramine-treated patients with obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

Desensitization of the neuronal 5-HT carrier following its long-term blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

5-HT1D receptors regulate 5-HT release in the rat raphe nuclei. In vivo voltammetry and in vitro superfusion studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

The role of 5-HT(1B/1D) receptors in the modulation of 5-hydroxytryptamine levels in the frontal cortex of the conscious guinea pig.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

Clinical Effects of the 5-HT1A Partial Agonists in Depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

Effect of pindolol on the function of pre- and postsynaptic 5-HT1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

Effects of selective h5-HT1B (SB-216641) and h5-HT1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroreceptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

Extracellular serotonin levels change with behavioral state but not with pyrogen-induced hyperthermia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

How long should pindolol be associated with paroxetine to improve the antidepressant response?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900114-0

10.1016/S0006-3223(98)00114-0

7 January 2021

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018